How ageing processes influence cancer

  title={How ageing processes influence cancer},
  author={Jo{\~a}o Pedro de Magalh{\~a}es},
  journal={Nature Reviews Cancer},
The ageing of populations worldwide is leading to an unprecedented increase in cancer cases and fatalities. Understanding the links between cancer and ageing is therefore more important than ever. How the interplay of ageing-associated changes affects cancer initiation and progression is complex, however, and some ageing processes probably foster cancer development whereas others hinder it, possibly in a tissue-specific manner. In the emerging age of cancer, how can our growing understanding of… 
The Biology of Aging and Cancer: A Complex Association
Understanding the common cellular and molecular biology of stem and progenitors cells in cancer and aging will undoubtedly help in exploring novel targets that could be used as a therapy and thus can improve the early detection and treatment of aging-associated pathologies such as cancer.
A Human Tissue-Specific Transcriptomic Analysis Reveals that Ageing Hinders Cancer and Boosts Cellular Senescence
This work suggests that in most human tissues ageing processes and senescence act in tandem while being detrimental to cancer, and challenges the traditional view concerning the relationship between cancer and ageing.
Ageing, cellular senescence and the impact of diet: an overview
The cellular and molecular mechanisms involved in cellular senescence are highlighted and some of the research that is being done about how environmental conditions such as diet can affect the accumulation of senescent cells are discussed.
Age influences on the molecular presentation of tumours
It is shown that age shapes the somatic mutational landscape of cancer, with clinical implications, and known cancer driver genes such as CDKN2A and CREBBP are mutated in age-associated frequencies, and these alter the transcriptome and predict for clinical outcomes.
Analysis of cancer genomes reveals basic features of human aging and its role in cancer development
The analyses suggest that age-associated mutation load and burden double approximately every 8 years, similar to the all-cause mortality doubling time, and offers a mechanism for age being a risk factor for the onset of cancer.
Aging and cancer: Is glucose a mediator between them?
The new evidence adds to the concepts that have been being developed starting from mid-1970ies to suggest that age-related shifts in glucose and lipid metabolism increase the risk of cancer and compromise prognoses for cancer patients and to propose antidiabetic biguanides, including metformin, for cancer prevention and as an adjuvant means of cancer treatment aimed at the metabolic rehabilitation of patients.
Eco‐evolutionary perspectives of the dynamic relationships linking senescence and cancer
It is argued that cancer itself can promote senescence by notably increasing the amount of resources required for somatic maintenance, and similar evolutionary forces might shape the synchronicity ofsenescence and cancer patterns, which emphasize the tight and complex relationships linking these processes.
Aging and radiation: bad companions
The mechanistic interplay between increasing inflammatory response, loss of oxidant/antioxidant equilibrium, ongoing telomere attrition, decline in the DNA damage response efficiency, and deleterious nuclear organization are age‐related cellular changes that trigger a serious threat to genomic integrity.
Identification of polymorphisms in cancer patients that differentially affect survival with age
This is the first systematic analysis that combines a large longitudinal data set with a targeted candidate gene approach to examine the effect of genetic variation on survival as a function of age in cancer patients, demonstrating that there are ageing-related genetic elements that differentially affect mortality incancer patients in an age-dependent manner.
Physiology and Ageing
  • R. Watson
  • Medicine, Biology
    Perspectives in Nursing Management and Care for Older Adults
  • 2021
The aim of this chapter is to consider why we age and what the underlying processes are before considering the effects of ageing on the systems of the body. Where possible, the distinction between


Cancer and ageing: a nexus at several levels
New insights into the underlying biological processes of ageing provide a frame of reference for addressing questions about the development or growth of cancer and the benefits and risks of cancer prevention and treatment for the older person.
The common biology of cancer and ageing
The series of key observations that has led to a complex but growing convergence between the understanding of the biology of ageing and the mechanisms that underlie cancer are reviewed.
From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing.
In this review, widely used models for studying ageing in cell culture, such as Hayflick's, are interpreted in the context of the human ageing process and mechanisms behind cellular senescence such as telomere disruption and DNA damage are reviewed and their relation to human ageing debated.
Aging and cancer: issues of basic and clinical science.
This review has attempted to frame questions regarding cancer and aging from the perspective of biogerontology and geriatric medicine to address the issues of aging at all levels of cancer investigation.
The relationship between aging and carcinogenesis: a critical appraisal.
  • V. Anisimov
  • Medicine, Biology
    Critical reviews in oncology/hematology
  • 2003
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer.
Results provide direct proof of the anti-ageing activity of Sirt1 in mammals and of its tumour suppression activity in ageing- and metabolic syndrome-associated cancer.
How does SIRT1 affect metabolism, senescence and cancer?
It is proposed that the net outcome of the seemingly opposite oncogenic and tumour-suppressive effects of SIRT1 depends on the status of p53.
Genome-Environment Interactions That Modulate Aging: Powerful Targets for Drug Discovery
A broad range of findings in model organisms are reviewed, from environmental to genetic manipulations of aging, with a focus on those with underlying gene-environment interactions with potential for drug discovery and development.